Case number 1:22-cv-01102
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Dr. Reddy's Laboratories Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 18, 2022 | 14 | SO ORDERED, re (13 in 1:22-cv-01102-CFC) STIPULATION and Order to Consolidate and Stay Proceedings. 1. This case is hereby CONSOLIDATED with the Lead Case, 21-cv-1485-CFC; and 2. Consistent with that consolidation, this case is STAYED pending resolution of a motion to be filed by Defendants regarding the enforceability of the '323 Patent. Signed by Judge Colm F. Connolly on 10/18/2022. (nmf) (Entered: 10/18/2022) (3) |
| Oct 17, 2022 | 13 | STIPULATION and [Proposed] Order to Consolidate and Stay Proceedings by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 10/17/2022) (3) |
| Oct 12, 2022 | 12 | STIPULATION TO EXTEND TIME for Plaintiffs to move, answer, or otherwise respond to Defendants' Answer, Affirmative Defenses and Counterclaims for Declaratory Judgment (D.I. 9) to October 20, 2022 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 10/12/2022) (2) |
| Sep 26, 2022 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Jovial Wong and Chang Hahn - filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # 1 Certification of Jovial Wong, # 2 Certification of Chang Hahn)(Bilson, David) (Entered: 09/26/2022) (Main Document) (2) |
| Sep 26, 2022 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Jovial Wong and Chang Hahn - filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # 1 Certification of Jovial Wong, # 2 Certification of Chang Hahn)(Bilson, David) (Entered: 09/26/2022) (Certification of Jovial Wong) (1) |
| Sep 26, 2022 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Jovial Wong and Chang Hahn - filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # 1 Certification of Jovial Wong, # 2 Certification of Chang Hahn)(Bilson, David) (Entered: 09/26/2022) (Certification of Chang Hahn) (1) |
| Sep 22, 2022 | 9 | ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories Ltd..(Phillips, John) (Entered: 09/22/2022) (30) |
| Sep 22, 2022 | 10 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dr. Reddy's Laboratories, Ltd. for Dr. Reddy's Laboratories, Inc. filed by Dr. Reddy's Laboratories Ltd., Dr. Reddy's Laboratories, Inc.. (Phillips, John) (Main Document 10 replaced on 9/22/2022) (kmd). (Entered: 09/22/2022) (2) |
| Sep 2, 2022 | 7 | AFFIDAVIT of Service for for Summons, Complaint and related papers served on Dr. Reddys Laboratories Ltd on September 1, 2022, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 09/02/2022) (10) |
| Sep 2, 2022 | 8 | AFFIDAVIT of Service for Summons, Complaint and related papers served on Dr. Reddy's Laboratories, Inc. on September 1, 2022, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) (Entered: 09/02/2022) (10) |
| Aug 22, 2022 | 1 | Complaint* (1) |
| Aug 22, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 08/23/2022) (3) |
| Aug 22, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 07/21/2022. Date of Expiration of Patent: 04/03/2034. (vfm) (Entered: 08/23/2022) (1) |
| Aug 22, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,090,323 B2. (vfm) (Entered: 08/23/2022) (1) |
| Aug 22, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C.H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Corporation filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, and Boehringer Ingelheim Corporation (vfm) (Entered: 08/23/2022) (2) |
| Aug 22, 2022 | 6 | Summons were issued to Dr. Reddy's Laboratories Ltd on 8/22/2022; Dr. Reddy's Laboratories, Inc. on 8/22/2022 (vfm) (Main Document 6 replaced on 8/23/2022) (apk). (Additional attachment(s) added on 8/23/2022: # 1 Summons Issued) (apk). (Entered: 08/23/2022) (Main Document) (2) |
| Aug 22, 2022 | 6 | Summons were issued to Dr. Reddy's Laboratories Ltd on 8/22/2022; Dr. Reddy's Laboratories, Inc. on 8/22/2022 (vfm) (Main Document 6 replaced on 8/23/2022) (apk). (Additional attachment(s) added on 8/23/2022: # 1 Summons Issued) (apk). (Entered: 08/23/2022) (Summons Issued) (2) |
